Peter Friedmann to Narcotics
This is a "connection" page, showing publications Peter Friedmann has written about Narcotics.
Connection Strength
1.209
-
Stein MD, Friedmann PD. Optimizing opioid detoxification: rearranging deck chairs on the Titanic. J Addict Dis. 2007; 26(2):1-2.
Score: 0.272
-
Warner EA, Friedmann PD. Laboratory testing for drug abuse. Arch Pediatr Adolesc Med. 2006 Aug; 160(8):854, author reply 854.
Score: 0.264
-
Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005 Nov; 20(11):1038-41.
Score: 0.251
-
Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, Friedmann PD. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005 Sep; 82(3):411-9.
Score: 0.243
-
Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy? J Addict Med. 2012 Sep; 6(3):179-85.
Score: 0.101
-
Friedmann PD, Alexander JA, Yey Y, Nahra T, Soliman S, Pollack HA. Duration of nonmethadone outpatient treatment: results from a national survey. Subst Abus. 2006 Sep; 27(3):47-53.
Score: 0.066
-
Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003 May; 98(5):673-84.
Score: 0.013